On June 29th, the award ceremony for the VB-Link Future Medical Specialty Innovative Solution Challenge (hereinafter referred to as the VB-Link Competition) was held at the Intercontinental Hotel in Jiabao, Tianjin Economic-Technological Development Area. After intense competition at the national finals, Hopstem's "iPSC Cell Therapy Products and Organoids Platform" project won the third prize in the field of neurology.
Based on the winning projects of this competition, they cover various areas such as innovative medical devices, biopharmaceuticals, and digital therapies, including organoids platforms, plant intervention devices, ophthalmic surgical robots, gene therapy drugs, etc. The types are diverse and novel, injecting fresh blood into the industry for high-quality development.
Hopstem Wins the Third Prize of VB-Link Competition
Huayi List: Hopstem Ranks Top 10 Most Promising Biotech Companies
The iPSC-derived Human Forebrain Neural Progenitor Cell Injection hNPC01 of Hopstem has Received CDE's Clinical Implication Approval
The launch meeting of the clinical research project of Hopstem hNPC01 universal cell therapy product for the treatment of stroke sequelae was successfully held.